Predicted to enable identical protein binding activity and protein tyrosine phosphatase activity. Involved in negative regulation of insulin receptor signaling pathway. Predicted to be located in cytoplasm; nucleus; and plasma membrane. Orthologous to human PTPRE (protein tyrosine phosphatase receptor type E). [provided by Alliance of Genome Resources, Apr 2022]